Population (mio.): 83.7 (per 2022)
GDP per capita (US$/EUR): 48,718/44,784 (per 2022)
Healthcare expenditure % of GDP: 12.65% (per 2022)
Healthcare expenditure per capita (US$/EUR): 8,010/7,363 (per 2022)
Healthcare model and general information on healthcare system (financing, stakeholders, insurance): In Germany, health insurance is provided by two subsystems: statutory health insurances (95 insurances), competitive but not-for-profit and nongovernmental health insurance and private health insurance (42 insurances). Statutory health insurances are financed through general wage contributions and a dedicated, supplementary contribution, both shared by employers and workers. Approximately 87,3 % of the population is enrolled in statutory health insurances and the rest in private health insurances or specific programs for public sector employees.
Administration is managed by the statutory health insurances. The federal government has wide-ranging regulatory power over healthcare but is not directly involved in care delivery. The Federal Joint Committee, which is supervised by the Federal Ministry of Health, determines the services to be covered by statutory health insurances.
Read more about the healthcare system in Germany here.
Cooperation between Germany and Denmark: Denmark and Germany has established peer-to-peer cooperation at ministry and agency level within the health sector. The cooperation contributes to solving global health challenges by sharing experiences, best practices and public-private solutions within three priority areas: Healthcare of tomorrow, Health innovation and data and Regulation of pharmaceuticals and medical devices. The cooperation also serves as a platform for enhancing engagement of the Danish private sector in providing health sector solutions in the partner country.
The Danish-German health cooperation is led by the Ministry of the Interior and Health of Denmark and the Danish embassy in Germany in collaboration with The Danish Health Data Authority, Statens Serum Instititut, Danish Health Authority and Danish Medicines Agency. German partners are: The Federal Ministry of Health (Bundesministerium für Gesundheit), Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukter) and the Robert Koch-Institut. The cooperation is financed under the Danish Strategy for Life Science.
Head of RBIG, Robert Bosch Center for Innovative Health (RBIG)
Dr. Ingrid Wünning Tschol was Senior Vice-President, Health and Research, at the Robert Bosch Foundation (1999-2022), Head of Medical Section at the European Science Foundation in Strasbourg, Head of Molecular Biology Unit at Dt. Forschungsgemeinschaft in Bonn (1985-1990), and a postdoctoral researcher at Massachusetts Institute of Technology in Cambridge, US. Ingrid is and was a member of numerous national and international committees in Europe and Africa. She has a PhD in Biology from the University of Tübingen.
Director General and Chief Medical Officer, Directorate-General for Public Health, Federal Ministry of Health, Germany
Dr. Ute Teichert has been Head of the “Public Health” department at the Federal Ministry of Health since 2022. As a public health specialist and public health graduate she has been working in the public health service since 2001, including as Head of the Ahrweiler health authority (Rheinland-Pfalz) from 2002 to 2012. From 2014 to 2022, she headed the Academy for Public Health in Düsseldorf. She was also Chairwoman of the Federal Association of Doctors in the Public Health Service (2010 to 2022).
Managing Partner, Institut für angewandte Versorgungsforschung
Prof. Dr. Volker Amelung has held a professorship for International Health Systems Research at the Hannover Medical School since 2001.
From 2007 to 2022, he was Chairman of the Board of the Bundesverband Managed Care e. V. (BMC).
In 2011, he founded inav – Private Institut für Angewandte Versorgungsforschung GmbH (Private Institute for Applied Health Services Research), which he heads as managing partner. Volker Amelung’s research focuses on the areas of managed care and integrated care.
CEO, Health Care Bayern (Bavaria) e.V.
Claudia Küng is CEO of the non-profit association Health Care Bayern e.V., a well-known health care network in Bavaria (over 450 members). She is responsible for the annual European Health Congress in Munich and the Health Care Congress of the West, events for decision-makers in the health industry. She holds a degree in economics and teaches health policy and health economics as a lecturer at the TU of Munich. She was distinguished with the medal “Special Merits for Bavaria in a united Europe.”
